Given our passion for quality anaerobic microbiology technique, you can imagine how excited we were to see the Bactron IV/900 in this news article about the new DANONE Research Centre for Special Nutrition in Singapore. Recently we have been answering a lot of inquiries about using anaerobic techniques for food and beverage quality assurance, and would encourage you to contact us with any questions you may have about the Bactron line.
From the Article:
Danone to invest S$70m in R&D centre in Singapore
SINGAPORE : International food company Danone will be investing some S$70 million over the next five years in a specialised research and development centre in Singapore.
The global player said the Danone Research Centre for Specialised Nutrition focuses on child and maternal health and is the first of its kind in Asia Pacific.
It is targeting to have a team of 50 scientists based at the centre in the next five years.
The centre looks at areas such as the impact of nutrition on gut bacteria, immune system and the overall growth and development of babies and children.
Danone said that it hopes to provide state of the art products, and added that one of the reasons for positioning the centre in Singapore was to be close to business.
Eline Van Der Beek, research director at Danone Research, said: “Asia Pacific is very important to us, and Singapore is a very important starting place to meet the whole Asia Pacific region. The second reason is of course the scientific environment here in Singapore being very open and very mature.”
Danone is present in over 120 countries on five continents. In 2010, Danone had more than 160 production plants and around 100,000 employees, generating sales of over S$30 billion, of which 50 per cent were in emerging economies.
Julian Ho, assistant managing director at the Economic Development Board Singapore, said: “Singapore is proud to host Danone’s Asia-Pacific hub for research and innovation – the first in Asia for Danone to focus fully on science for child and maternal health.
“The new centres at Biopolis would be able to benefit from the synergies between Singapore’s world-class biomedical research capabilities and access scientific insights in Asia Pacific.”
- CNA/ms